-
Mashup Score: 23
Listen to this episode from Trials and Tribulations | Oncology Trials Podcast on Spotify. In episode 1, we discuss the STAMPEDE2 trial site set-up, ethics and MHRA issues.
Source: open.spotify.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 216th Bladder Cancer Translational Research Meeting - 2 month(s) ago
The Bladder Cancer Research Centre (University of Birmingham) and the Translational Oncology & Urology Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 5th Bladder Cancer Translational Research Meeting – a fully interactive bladder cancer clinical research meeting led by an international expert panel of clinicians and scientists in the U.K. The forum is designed to bridge the gap between science and clinical practice and will cover the spectrum of bladder cancer research in oncology, urology, nursing, epidemiology, immuno- and molecular biology.
Source: www.kcl.ac.ukCategories: General Medicine News, Hem/OncsTweet-
Not too late to register for the 6th Annual Bladder Translational Meeting - always a high quality event! https://t.co/tYmErXUU5f
-
-
Mashup Score: 36The Lancet Commission on Prostate Cancer: preparing for the forthcoming global surge in cases | London Global Cancer Week - 6 month(s) ago
Register Now The Lancet Commission on Prostate Cancer: preparing for the forthcoming global surge in cases Hosted by: Centre for Global OncologyTue 14th November @ 12:30 pm – 2:00 pm GMT Prostate cancer is already the commonest male cancer in 112/185 countries and accounts for 15% of all male cancers. Due to projected demographic changes worldwide, coupled to rising life expectancy, cases will…
Source: www.lgcw.org.ukCategories: General Medicine News, Hem/OncsTweet-
Proud to present a session at London Global Cancer Week on prostate cancer 14 Nov at 12.30-14.00 UTC with a discussion about issues identified in our Lancet Commission on the topic @ICR_London @TheLancet Free registration - do join us! https://t.co/LYbdqrvW11
-
-
Mashup Score: 75How to Compose Platform Trials - 6 month(s) ago
Platform trials are adaptive randomised controlled trials that address multiple questions using a single protocol, which reduces the time taken to rea…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet-
Our latest article on platform trials - Noel Clarke and I reflect on issues relating to set up and running such a study based on our experience with STAMPEDE and the setting up of STAMPEDE2 @ICR_London @MRCCTU https://t.co/IPXxyveVCA
-
-
Mashup Score: 6Selenium and Vitamin E for Non–Muscle-Invasive Bladder Cancer - 6 month(s) ago
This randomized clinical trial assesses the ability of selenium and vitamin E to prevent non–muscle-invasive bladder cancer (NMIBC) recurrence and progression in patients with newly diagnosed disease.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Latest data from #BCPP embedded 2x2 RCT of selenium and vitamin E secondary prevention of bladder cancer. Se did not reduce risk of recurrence, vit E supplementation increased risk of recurrence. Not all vitamin therapy benign! https://t.co/202SVLnYWA
-
-
Mashup Score: 2Clinical Research Fellow in Urological Cancer - STAMPEDE2 trial Arm P- ( ID 628) in Chelsea (London) | The Institute of Cancer Research - 11 month(s) ago
View details and apply for this Clinical Research Fellow in Urological Cancer – STAMPEDE2 trial Arm P- ( ID 628) vacancy in Chelsea (London). Salary : Future progression is based on annual performance review. This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If…
Source: The Institute of Cancer ResearchCategories: Hem/Oncs, Latest HeadlinesTweet-
The STAMPEDE2 trial is hiring. Come and join us as a clinical research fellow for our PSMA-Lu therapy arm. https://t.co/RjEK1K5h85
-
-
Mashup Score: 0Press corner - 11 month(s) ago
Highlights, press releases and speeches
Categories: Latest Headlines, UrologyTweet-
Here is the latest analysis on the screening evidence https://t.co/lISyf5ydMM https://t.co/GXYK1dSI6R
-
-
Mashup Score: 0Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit - 11 month(s) ago
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue Andrew Vickers and colleagues Screening for prostate cancer with prostate specific antigen (PSA) remains highly controversial because it is unclear whether the benefits of reduced prostate cancer mortality offset the harms of overdiagnosis…
Source: The BMJCategories: Latest Headlines, UrologyTweet-
And here is the @bmj_latest article on “informed choice” https://t.co/3WelG1m01A which it says “create overdiagnosis and inequity with minimal benefit”.
-
-
Mashup Score: 1Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit - 11 month(s) ago
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue Andrew Vickers and colleagues Screening for prostate cancer with prostate specific antigen (PSA) remains highly controversial because it is unclear whether the benefits of reduced prostate cancer mortality offset the harms of overdiagnosis…
Source: The BMJCategories: Hem/Oncs, Latest HeadlinesTweet-
You may want to read this article as well. https://t.co/elWQDuN077
-
-
Mashup Score: 1Press corner - 11 month(s) ago
Highlights, press releases and speeches
Categories: Hem/Oncs, Latest HeadlinesTweet-
Long term analysis of the European screening trial now justifies PSA screening and is recommending member states set this up https://t.co/lISyf5ydMM no need to wait for more evidence. UK NSC reviewing 🤞! https://t.co/RRNf8vZiD8
-
Episode 1 of our new podcast looking behind the scenes at trial set up now live - ethics and regulatory issues. Episode 2 on routine data access soon. Future episodes: first SIV #STAMPEDE2, international set up @Hoda_Aty @TrialsTribsPod https://t.co/P9RS6IuEIy